Patents by Inventor Andreas Raab

Andreas Raab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11955756
    Abstract: An electric terminal including a contact section having a locking lance locking the electric terminal in a connector housing of an electric connector and a transition section extending from the contact section and having a secondary latching with a secondary latching device latching the electric terminal in the connector housing. The locking lance is axially additionally secured in the contact section away from an attachment of the locking lance to the contact section and/or a plurality of side walls of the electric terminal are closed by a circumferential connection in the secondary latching device.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: April 9, 2024
    Assignee: TE Connectivity Germany GmbH
    Inventors: Daniel Leiminger, Jochen Brandt, Andreas Oettle, Stefan Raab, Ulrich Lechler, Marina Hertlein, Florian Staufinger, Jiri Konrad, Andreas Merkle, Julia Stegmeier (nee Kirschbaum)
  • Publication number: 20240106148
    Abstract: A two-part electrical pin-contact assembly, in particular a nano or pico pin-contact assembly for an electrical plug connection in the automotive sector, is provided. The two-part electrical pin-contact assembly includes a pin-contact device extending in a longitudinal direction and a contact body extending in the longitudinal direction. The pin-contact device is secured in the contact body by a primary locking and a secondary locking.
    Type: Application
    Filed: September 20, 2023
    Publication date: March 28, 2024
    Inventors: Fabian Waldsauer, Andreas Oettle, Stefan Raab
  • Publication number: 20240085783
    Abstract: An optical apparatus for a lithography system comprises at least one optical element comprising an optical surface. The optical apparatus also comprises one or more actuators for deforming the optical surface. A strain gauge device is provided for determining the deformation of the optical surface. The strain gauge device comprises at least one optical fiber that maintains polarization.
    Type: Application
    Filed: November 17, 2023
    Publication date: March 14, 2024
    Inventors: Markus Raab, Stefan Troeger, Sascha Bleidistel, Thilo Pollak, Alexander Vogler, Klaus Gwosch, Andreas Koeniger, Matthias Manger
  • Publication number: 20240085800
    Abstract: A component for a projection exposure apparatus for semiconductor lithography, comprises an optical element and an actuator, which are force-fittingly connected to each other. The actuator at least locally deforms the optical element. The actuator can be configured to minimize the loss in rigidity at the peripheries delimiting the actuator on the imaging quality. A method for designing a component of projection exposure apparatus is provided.
    Type: Application
    Filed: November 13, 2023
    Publication date: March 14, 2024
    Inventors: Thilo Pollak, Dietmar Duerr, Irina Schrezenmeier, Joerg Tschischgale, Matthias Manger, Andreas Beljakov, Stefan Baueregger, Alexander Ostendorf, Dieter Bader, Markus Raab, Bastian Keller
  • Publication number: 20240077714
    Abstract: A microscopy system includes a tracking camera for pose detection of a marker, a device configured to determine a working distance, a movable optical element, the pose of which can be changed to set a capture region of the tracking camera and/or at least two tracking illumination devices, at least one optical element for beam guidance of the radiation generated by the tracking illumination devices, and a controller configured to control the movable optical element and/or the tracking illumination devices, in which the pose of the movable optical element can be set based on the working distance and/or in which an operating mode and/or an illumination region of the tracking illumination devices can be set based on the working distance. In addition, a method for operating a microscopy system is provided.
    Type: Application
    Filed: November 7, 2023
    Publication date: March 7, 2024
    Inventors: Andreas Raab, Jonathan Essig, Stefan Ernsperger, Natalie Krieg, Andrè Müller
  • Publication number: 20230301739
    Abstract: A holding element for a drape for a surgical microscope is provided. The holding element has a holding ring and a recess located in the holding ring for an interface of the surgical microscope. The holding ring has an asymmetrical contour delimiting the recess such that in a condition in which the holding element is fastened to the surgical microscope there is only one possible fastening position of the holding element on the interface of the surgical microscope that corresponds to the contour of the holding ring, in which position an orientation of the holding element relative to the surgical microscope is defined.
    Type: Application
    Filed: May 27, 2023
    Publication date: September 28, 2023
    Inventors: Andreas Raab, Frank König
  • Publication number: 20230093637
    Abstract: A surgical microscope includes an image capture unit having an image sensor, a detection beam path, an image evaluation unit, a connection region for attaching a protective glass module with an objective protective glass. The image sensor has a detection region which has a used detection region for capturing the object region, and a partial detection region, which is not assigned to the used detection region. The image capture unit is configured such that, when the protective glass module with the objective protective glass is arranged at the connection region, a detail of the protective glass module with the objective protective glass is capturable by the partial detection region of the image sensor. The image evaluation unit is configured to generate a signal when an objective protective glass is detectable by the evaluation of the image data of the partial detection region of the image sensor.
    Type: Application
    Filed: September 17, 2022
    Publication date: March 23, 2023
    Inventors: Manuel Steidle, Andreas Raab
  • Publication number: 20210157112
    Abstract: To simplify the optical calibration of an optical observation apparatus, a stand for an optical observation unit including a calibration object arranged directly on the stand in a fixed location is specified. Moreover, an optical observation apparatus, which includes such a stand and an optical observation unit connected to the stand, a method for calibrating such an optical observation apparatus, and a computer program are specified.
    Type: Application
    Filed: November 20, 2020
    Publication date: May 27, 2021
    Inventors: Andreas Raab, Jonathan Essig, Dominik Scherer, Christian Voigt, Stefan Saur
  • Patent number: 10308971
    Abstract: The invention relates to an isolated, genetically modified, living non-mammal organism, having increased HMG-CoA-reductase activity compared to the wild type, and having reduced C24-methyltransferase and/or delta22-desaturase activity compared to the wild type. The invention is characterized in that the organism has increased dehydrocholesterol-delta70-reductase activity compared to the wild type. The invention further relates to different uses of such an organism, to a test kit comprising such an organism, and to a membrane extract of such an organism.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: June 4, 2019
    Assignee: Novozymes A/S
    Inventors: Michael Schilling, Christine Lang, Andreas Raab
  • Publication number: 20180171374
    Abstract: The invention relates to an isolated, genetically modified, living non-mammal organism, having increased HMG-CoA-reductase activity compared to the wild type, and having reduced C24-methyltransferase and/or delta22-desaturase activity compared to the wild type. The invention is characterized in that the organism has increased dehydrocholesterol-delta70-reductase activity compared to the wild type. The invention further relates to different uses of such an organism, to a test kit comprising such an organism, and to a membrane extract of such an organism.
    Type: Application
    Filed: February 7, 2018
    Publication date: June 21, 2018
    Applicant: Novozymes A/S
    Inventors: Michael Schilling, Christine Lang, Andreas Raab
  • Patent number: 9920348
    Abstract: The invention relates to an isolated, genetically modified, living non-mammal organism, having increased HMG-CoA-reductase activity compared to the wild type, and having reduced C24-methyltransferase and/or delta22-desaturase activity compared to the wild type. The invention is characterized in that the organism has increased dehydrocholesterol-delta70-reductase activity compared to the wild type. The invention further relates to different uses of such an organism, to a test kit comprising such an organism, and to a membrane extract of such an organism.
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: March 20, 2018
    Assignee: Novozymes A/S
    Inventors: Michael Schilling, Christine Lang, Andreas Raab
  • Patent number: 9598710
    Abstract: The invention provides an isolated genetically modified non-mammalian organism, wherein the activity of acyl-CoA:sterol acyltransferase/sterol O-acyltransferase (EC 2.3.1.26) and/or diacylglycerol acyltransferase/diacylglycerol O-acyltranferase (EC 2.3.1.20) and/or lecithin cholesterol acyl transferase/phospholipid:diacylglycerol acyltransferase (EC 2.3.1.158) and/or acyl CoA-wax alcohol acyltransferase (EC 2.3.1.75) is reduced or abolished in comparison with a corresponding wildtype organism, methods of use of such an organism, shuttle vehicles for making such an organism and methods for producing such an organism.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: March 21, 2017
    Assignee: ORGANOBALANCE GMBH
    Inventors: Christine Lang, Andreas Raab
  • Patent number: 9585922
    Abstract: The invention relates to a microorganism, of the order of lactic acid bacteria or analog, fragment, derivative, mutant or combination thereof. Said microorganism, or analog, fragment, derivative, mutants or combinations thereof can be co-aggregated with at least Staphylococcus aureus or Pseudomonas aeruginosa.
    Type: Grant
    Filed: May 7, 2012
    Date of Patent: March 7, 2017
    Assignee: ORGANOBALANCE MEDICAL AG
    Inventors: Christine Lang, Andreas Raab, Patrick Golletz
  • Patent number: 9346484
    Abstract: In a device for releasing a securing screw for a unit in a housing, in particular a pinion unit in a steering gear of a motor vehicle, the securing screw is connected via an external thread to an internal thread in the housing, wherein the securing screw is provided with a latching device, which has latching levers disposed distributed on the circumference of the securing screw, each of which said latching levers is provided with latching lugs disposed on the free ends of the latching levers. The latching lugs latch into teething gaps of a teething geometry of the housing. The latching devices can be connected to a tool in order to release the latching levers having the latching lugs from the latched position by means of a radially inwardly directed movement of the latching levers.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: May 24, 2016
    Assignee: Robert Bosch Automotive Steering GmbH
    Inventors: Andreas Raab, Andreas Stahl
  • Patent number: 9308227
    Abstract: The invention describes a microorganism of the order of lactic acid bacteria or an analog, fragment, derivative, mutant or combination thereof, wherein the microorganism, or analog, fragment, derivative, mutant or combination thereof can coaggregate with Streptococcus pyogenes.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: April 12, 2016
    Assignee: ORGANOBALANCE MEDICAL AG
    Inventors: Christine Lang, Andreas Raab, Natalia Bolotina
  • Patent number: 9051587
    Abstract: The present invention relates to a yeast cell, wherein said cell comprises a functional gene coding for soluble hydroxymethylglutaryl-coenzyme-A (HMG-CoA) reductase; one or more gene(s) coding for steryl acyltransferase(s) in said cell are defective or deleted; and said cell is prototrophic for at least histidine, leucine or uracil. Moreover, the present invention relates to the use of said cell for the production of one or more terpene(s). Further, the present invention relates to methods of generating said cell and the production of one or more terperne(s) and a pharmaceutical or cosmetically composition, a lubricant or transformer oil comprising said terpene(s).
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: June 9, 2015
    Assignee: OrganoBalance GmbH
    Inventors: Andreas Raab, Christine Lang
  • Publication number: 20150093781
    Abstract: The invention relates to an isolated, genetically modified, living non-mammal organism, having increased HMG-CoA-reductase activity compared to the wild type, and having reduced C24-methyltransferase and/or delta22-desaturase activity compared to the wild type. The invention is characterized in that the organism has increased dehydrocholesterol-delta70-reductase activity compared to the wild type. The invention further relates to different uses of such an organism, to a test kit comprising such an organism, and to a membrane extract of such an organism.
    Type: Application
    Filed: August 13, 2014
    Publication date: April 2, 2015
    Inventors: Michael Schilling, Christine Lang, Andreas Raab
  • Publication number: 20150024009
    Abstract: The invention provides an isolated genetically modified non-mammalian organism, wherein the activity of acyl-CoA:sterol acyltransferase/sterol O-acyltransferase (EC 2.3.1.26) and/or diacylglycerol acyltransferase/diacylglycerol O-acyltranferase (EC 2.3.1.20) and/or lecithin cholesterol acyl transferase/phospholipid: diacylglycerol acyltransferase (EC 2.3.1.158) and/or acyl CoA-wax alcohol acyltransferase (EC 2.3.1.75) is reduced or abolished in comparison with a corresponding wildtype organism, methods of use of such an organism, shuttle vehicles for making such an organism and methods for producing such an organism.
    Type: Application
    Filed: September 19, 2014
    Publication date: January 22, 2015
    Applicant: ORGANOBALANCE GMBH
    Inventors: Christine Lang, Andreas Raab
  • Patent number: 8841114
    Abstract: The invention provides an isolated genetically modified non-mammalian organism, wherein the activity of acyl-CoA: sterol acyltransferase/sterol O-acyltransferase (EC 2.3.1.26) and/or diacylglycerol acyltransferase/diacylglycerol O-acyltranferase (EC 2.3.1.20) and/or lecithin cholesterol acyl transferase/phospholipid: diacylglycerol acyltransferase (EC 2.3.1.158) and/or acyl CoA-wax alcohol acyltransferase (EC 2.3.1.75) is reduced or abolished in comparison with a corresponding wildtype organism, methods of use of such an organism, shuttle vehicles for making such an organism and methods for producing such an organism.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: September 23, 2014
    Assignee: OrganoBalance GmbH
    Inventors: Christine Lang, Andreas Raab
  • Publication number: 20140186409
    Abstract: The invention relates to a microorganism, of the order of lactic acid bacteria or analog, fragment, derivative, mutant or combination thereof. Said microorganism, or analog, fragment, derivative, mutants or combinations thereof can be co-aggregated with at least Staphylococcus aureus or Pseudomonas aeruginosa.
    Type: Application
    Filed: May 7, 2012
    Publication date: July 3, 2014
    Applicant: ORGANOBALANCE MEDICAL AG
    Inventors: Christine Lang, Andreas Raab, Patrick Golletz